A method of reducing damage to cells and tissue caused by an ischemic or
hypoxic event is disclosed. The method includes administering to the cell
or tissue, either in vivo or ex vivo, .psi..epsilon.RACK peptide. The
peptide can be administered before, during or after the ischemic or
hypoxic event.